Investigate the Safety/Tolerability and Efficacy of Bilastine 20mg in Korean Patients With Seasonal Allergic Rhinitis
Status:
Completed
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
The objective of the study was to determine the efficacy and tolerability of 20 mg of
Bilastine, compared to Desloratadine and placebo for the treatment of Seasonal Allergic
Rhinitis.